Loading news...
4D Molecular Therapeutics raised $75M Series C venture round, led by Viking Global Investors.
This funding round does not have an about section yet.
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$168M
Top Valuation
-
4D Molecular Therapeutics raised $75M in a Series C round.
The round was announced on 06/16/20.
The round was led by Viking Global Investors.